Copaxone
 | This article is a stub. |
Copaxone or glatopa, and glatiramer, its generic form, is a drug licensed to reduce relapses in patients with multiple sclerosis.[1]
Contents
ME/CFS[edit | edit source]
Ron Davis of the Open Medicine Foundation reports that when the nanoneedle electrical impedance test on ME/CFS cells was used, Copaxone made the cells respond in the same way as healthy cells did, suggesting it is a potential treatment for ME/CFS.[2]
See also[edit | edit source]
Learn more[edit | edit source]
- Copaxone - drugs.com
References[edit | edit source]
- ↑ "Copaxone: Uses, Dosage, Side Effects". Drugs.com. Retrieved Apr 30, 2019.
- ↑ Davis, Ron (Sep 2019). "Dr. Ron Davis Presents on ME/CFS Research Activities at Stanford at Inaugural Harvard Symposium". Retrieved Sep 8, 2019.
ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.
nanoneedle - A device with microscopic dimensions which measures electrical impedance across a blood cell. According to Ron Davis, the nanoneedle measured increased electrical impedance in the blood cells of 10 ME/CFS patients when stressed with salt, but not in healthy controls. Accordingly, this device has been proposed as a potential diagnostic test to distinguish ME/CFS patients from healthy controls. (Learn more: www.omf.ngo)
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
